{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:10:03Z","timestamp":1793045403151,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.drudis.2021.07.012","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T02:29:43Z","timestamp":1626920983000},"page":"2774-2781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia"],"prefix":"10.1016","volume":"26","author":[{"given":"Manjula","family":"Miglani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qadar","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Priyadarshini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramendra","family":"Pati Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpana","family":"Vibhuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM200107123450206","article-title":"High-altitude illness","volume":"345","author":"Hackett","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.drudis.2021.07.012_b0010","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1152\/japplphysiol.01167.2004","article-title":"Physiological aspects of high-altitude pulmonary edema","volume":"98","author":"B\u00e4rtsch","year":"2005","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2049-6958-6-1-14","article-title":"The lung at high altitude","volume":"6","author":"Cogo","year":"2011","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0020","first-page":"29","article-title":"To decipher the hypoxic pulmonary hypertension: vascular heterogeneity and the hypothesis of hypoxic responsive threshold","volume":"9","author":"Ma","year":"2015","journal-title":"J Med Hypo"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.emc.2017.01.002","article-title":"Advances in the prevention and treatment of high altitude illness","volume":"35","author":"Davis","year":"2017","journal-title":"Emerg Med Clin North Am"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000336625","article-title":"Gene polymorphisms and high-altitude pulmonary edema susceptibility: a 2011 update","volume":"84","author":"Luo","year":"2012","journal-title":"Respiration"},{"issue":"18","key":"10.1016\/j.drudis.2021.07.012_b0035","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1113\/JP270651","article-title":"Impact of extreme exercise at high altitude on oxidative stress in humans","volume":"594","author":"Quindry","year":"2016","journal-title":"J Physiol"},{"issue":"9","key":"10.1016\/j.drudis.2021.07.012_b0040","first-page":"1103","article-title":"Altitude illness: risk factors, prevention, presentation, and treatment","volume":"82","author":"Fiore","year":"2010","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/genes10020150","article-title":"Human genetic adaptation to high altitude: evidence from the Andes","volume":"10","author":"Julian","year":"2019","journal-title":"Genes (Basel)"},{"issue":"11","key":"10.1016\/j.drudis.2021.07.012_b0050","first-page":"499","article-title":"High altitude illness and related diseases- a review","volume":"105","author":"Gudbjartsson","year":"2019","journal-title":"Laeknabladid"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ham.2019.0083","article-title":"Genetic predisposition to high-altitude pulmonary edema","volume":"21","author":"Eichstaedt","year":"2020","journal-title":"High Alt Med Biol"},{"issue":"7","key":"10.1016\/j.drudis.2021.07.012_b0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200809-1398OC","article-title":"Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease","volume":"179","author":"Savale","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.drudis.2021.07.012_b0065","first-page":"1213","article-title":"In silico design of telomerase inhibitors Drug Discov","volume":"25","author":"Baginski","year":"2020","journal-title":"Today"},{"issue":"13","key":"10.1016\/j.drudis.2021.07.012_b0070","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.18632\/aging.103504","article-title":"Physical activity, a modulator of aging through effects on telomere biology","volume":"12","author":"Semeraro","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.drudis.2021.07.012_b0075","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2019.4191","article-title":"Association of nutraceutical supplements with longer telomere length","author":"Tsoukalas","year":"2019","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.drudis.2021.07.012_b0080","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg1656","article-title":"Telomeres and human disease: ageing, cancer and beyond","volume":"6","author":"Blasco","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0085","first-page":"28","article-title":"Telomeres, lifestyle, cancer, and aging","volume":"14","author":"Shammas","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1566524053586545","article-title":"Telomeres as biomarkers for ageing and age-related diseases","volume":"5","author":"Zglinicki","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.drudis.2021.07.012_b0095","doi-asserted-by":"crossref","unstructured":"Starkweather AR, Alhaeeri AA, Montpetit A, Brumelle J, Filler K, Montpetit M, et al. An integrative review of factors associated with telomere length and implications for biobehavioral research. Nurs Res 2014; 63(1): 36\u201350.","DOI":"10.1097\/NNR.0000000000000009"},{"issue":"9","key":"10.1016\/j.drudis.2021.07.012_b0100","doi-asserted-by":"crossref","first-page":"e199687","DOI":"10.1001\/jamanetworkopen.2019.9687","article-title":"Association of short-term change in leukocyte telomere length with cortical thickness and outcomes of mental training among healthy adults: a randomized clinical trial","volume":"2","author":"Puhlmann","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.drudis.2021.07.012_b0105","doi-asserted-by":"crossref","unstructured":"\u00c5str\u00f6m MJ, von Bonsdorff MB, Per\u00e4l\u00e4 MM, Salonen MK, Rantanen T, Kajantie E, et al. Telomere length and physical performance among older people\u2013The Helsinki Birth Cohort Study. Mech Ageing Dev 2019; 183: 111145.","DOI":"10.1016\/j.mad.2019.111145"},{"issue":"3","key":"10.1016\/j.drudis.2021.07.012_b0110","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1172\/JCI66370","article-title":"Telomeres and age-related disease: how telomere biology informs clinical paradigms","volume":"123","author":"Armanios","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.drudis.2021.07.012_b0115","doi-asserted-by":"crossref","unstructured":"Richards JB, Valdes AM, Gardner JP, Paximadas D, Kimura M, Nessa A, et al. Higher serum vitamin D concentrations are associated with longer leukocyte telomere length in women. Am J Clin Nutr 2007; 86(5): 1420\u20131425.","DOI":"10.1093\/ajcn\/86.5.1420"},{"issue":"9","key":"10.1016\/j.drudis.2021.07.012_b0120","doi-asserted-by":"crossref","first-page":"e44049","DOI":"10.1371\/journal.pone.0044049","article-title":"Interactions among vascular-tone modulators contribute to high altitude pulmonary edema and augmented vasoreactivity in highlanders","volume":"7","author":"Ali","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbrc.2007.05.076","article-title":"Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD","volume":"359","author":"Vibhuti","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2021.07.012_b0130","first-page":"29","article-title":"Oxidative stress at high altitude: genotype\u2013phenotype correlations","volume":"4","author":"Pandey","year":"2014","journal-title":"Adv Genomics Genet"},{"issue":"5","key":"10.1016\/j.drudis.2021.07.012_b0135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.14336\/AD.2016.0215","article-title":"Oxidative stress-induced telomere length shortening of circulating leukocyte in patients with obstructive sleep apnea","volume":"7","author":"Kim","year":"2016","journal-title":"Aging Dis"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0140","first-page":"120","article-title":"8-Hydroxy-2\u2032 -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J Environ Sci Health"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0300-483X(02)00385-2","article-title":"Work at high altitude and oxidative stress: antioxidant nutrients","volume":"180","author":"Askew","year":"2002","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.drudis.2021.07.012_b0150","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.0000251281.00845.18","article-title":"Telomere biology and cardiovascular disease","volume":"99","author":"Fuster","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2021.07.012_b0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mad.2018.03.013","article-title":"The impact of oxidative DNA damage and stress on telomere homeostasis","volume":"177","author":"Barnes","year":"2019","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.drudis.2021.07.012_b0160","doi-asserted-by":"crossref","unstructured":"Krishna BH, Keerthi GS, Kumar CK, Reddy NM. Association of leukocyte telomere length with oxidative stress in yoga practitioners. J Clin Diagn Res 2015; 9(3): CC01\u2013CC03.","DOI":"10.7860\/JCDR\/2015\/13076.5729"},{"issue":"11","key":"10.1016\/j.drudis.2021.07.012_b0165","doi-asserted-by":"crossref","first-page":"20150396","DOI":"10.1098\/rsbl.2015.0396","article-title":"Telomere dynamics may link stress exposure and ageing across generations","volume":"11","author":"Haussmann","year":"2015","journal-title":"Biol Lett"},{"issue":"7","key":"10.1016\/j.drudis.2021.07.012_b0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.molmed.2020.03.005","article-title":"Reducing senescent cell burden in aging and disease","volume":"26","author":"Pignolo","year":"2020","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0175","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jmb.2008.03.058","article-title":"Zinc binding catalytic domain of human tankyrase 1","volume":"379","author":"Lehti\u00f6","year":"2008","journal-title":"J Mol Biol"},{"issue":"5393","key":"10.1016\/j.drudis.2021.07.012_b0180","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.282.5393.1484","article-title":"Tankyrase, a poly(ADP-ribose) polymerase at human telomeres","volume":"282","author":"Smith","year":"1998","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.drudis.2021.07.012_b0185","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/febs.12320","article-title":"Tankyrases as drug targets","volume":"280","author":"Lehti\u00f6","year":"2013","journal-title":"FEBS J"},{"issue":"10","key":"10.1016\/j.drudis.2021.07.012_b0190","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2174\/1389450117666160715152503","article-title":"Tankyrase as a novel molecular target in cancer and fibrotic diseases","volume":"18","author":"Lakshmi","year":"2017","journal-title":"Curr Drug Targets"},{"issue":"4","key":"10.1016\/j.drudis.2021.07.012_b0195","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/gcc.10250","article-title":"Poly(ADP-ribose) and carcinogenesis","volume":"38","author":"Masutani","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"41","key":"10.1016\/j.drudis.2021.07.012_b0200","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.2174\/1381612820666140630101525","article-title":"Tankyrases: structure, function and therapeutic implications in cancer","volume":"20","author":"Haikarainen","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.drudis.2021.07.012_b0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1196\/annals.1297.047","article-title":"Mechanism of telomere shortening by oxidative stress","volume":"1019","author":"Kawanishi","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.drudis.2021.07.012_b0210","doi-asserted-by":"crossref","unstructured":"Miglani M, Rain M, Pasha Q, Raj VS, Thinlas T, Mohammad G, et al. Shorter telomere length, higher telomerase activity in association with tankyrase gene polymorphism contribute to high-altitude pulmonary edema. Hum Mol Genet 2020; 29(18): 3094\u20133106.","DOI":"10.1093\/hmg\/ddaa205"},{"issue":"10","key":"10.1016\/j.drudis.2021.07.012_b0215","doi-asserted-by":"crossref","first-page":"691","DOI":"10.18632\/aging.100210","article-title":"Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs","volume":"2","author":"Dregalla","year":"2010","journal-title":"Aging (Albany NY)"},{"issue":"22","key":"10.1016\/j.drudis.2021.07.012_b0220","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1093\/nar\/gkm735","article-title":"Poly(ADP-ribosyl)ation in mammalian ageing","volume":"35","author":"Beneke","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"10.1016\/j.drudis.2021.07.012_b0225","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0960-9822(00)00752-1","article-title":"Tankyrase promotes telomere elongation in human cells","volume":"10","author":"Smith","year":"2000","journal-title":"Curr Biol"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biochi.2007.07.012","article-title":"Tankyrase function at telomeres, spindle poles, and beyond","volume":"90","author":"Hsiao","year":"2008","journal-title":"Biochimie"},{"issue":"5","key":"10.1016\/j.drudis.2021.07.012_b0235","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1291\/hypres.27.319","article-title":"Telomere attrition in white blood cell correlating with cardiovascular damage","volume":"27","author":"Nakashima","year":"2004","journal-title":"Hypertens. Res"},{"key":"10.1016\/j.drudis.2021.07.012_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bcp.2019.05.006","article-title":"Poly(ADP-ribose)-dependent ubiquitination and its clinical implications","volume":"167","author":"Vivelo","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"24","key":"10.1016\/j.drudis.2021.07.012_b0245","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1111\/bph.14038","article-title":"Regulation of Wnt\/\u03b2-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding","volume":"174","author":"Mariotti","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.drudis.2021.07.012_b0250","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1963","article-title":"Poly(ADP-ribose): novel functions for an old molecule","volume":"7","author":"Schreiber","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00018-019-03366-0","article-title":"Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity","volume":"77","author":"Eisemann","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"6082","key":"10.1016\/j.drudis.2021.07.012_b0260","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.1216338","article-title":"Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1","volume":"336","author":"Langelier","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.drudis.2021.07.012_b0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1021\/acsmedchemlett.6b00017","article-title":"Potential use of inhibitors of tankyrases and PARP-1 as treatment for cancer and other diseases","volume":"7","author":"Abdel-Magid","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"5","key":"10.1016\/j.drudis.2021.07.012_b0270","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccr.2009.10.007","article-title":"PARsing the phrase \u2018all in for Axin\u2019- Wnt pathway targets in cancer","volume":"16","author":"Fearon","year":"2009","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.drudis.2021.07.012_b0275","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/dvdy.22340","article-title":"Tankyrase is necessary for canonical Wnt signaling during kidney development","volume":"239","author":"Karner","year":"2010","journal-title":"Dev Dyn"},{"issue":"20","key":"10.1016\/j.drudis.2021.07.012_b0280","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1038\/sj.onc.1207460","article-title":"HIF-1-mediated activation of telomerase in cervical cancer cells","volume":"23","author":"Yatabe","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2021.07.012_b0285","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2009.05393.x","article-title":"Hyperbaric oxygen treatment induces antioxidant gene expression","volume":"1197","author":"Godman","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.drudis.2021.07.012_b0290","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1107\/S2053230X16004131","article-title":"Crystal structure of a tankyrase 1-telomere repeat factor 1 complex","volume":"72","author":"Li","year":"2016","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0295","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/cells8020199","article-title":"Histone modifications and the maintenance of telomere integrity","volume":"8","author":"Jezek","year":"2019","journal-title":"Cells"},{"issue":"5-6","key":"10.1016\/j.drudis.2021.07.012_b0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1101\/gad.334730.119","article-title":"Nuclear PARPs and genome integrity","volume":"34","author":"Azarm","year":"2020","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.drudis.2021.07.012_b0305","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.lungcan.2007.06.019","article-title":"Modulation of telomere shelterin by TRF1 corrected and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer","volume":"58","author":"Hsu","year":"2007","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0310","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/MCB.22.1.332-342.2002","article-title":"Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres","volume":"22","author":"Cook","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"16","key":"10.1016\/j.drudis.2021.07.012_b0315","doi-asserted-by":"crossref","first-page":"14116","DOI":"10.1074\/jbc.M112266200","article-title":"The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182)","volume":"277","author":"Seimiya","year":"2002","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.drudis.2021.07.012_b0320","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0960-9822(00)00752-1","article-title":"Tankyrase promotes telomere elongation in human cells","volume":"10","author":"Smith","year":"2000","journal-title":"Curr Biol"},{"issue":"3","key":"10.1016\/j.drudis.2021.07.012_b0325","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/BJ20060713","article-title":"Tankyrase recruitment to the lateral membrane in polarized epithelial cells: regulation by cell-cell contact and protein poly(ADP-ribosyl)ation","volume":"399","author":"Yeh","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2021.07.012_b0330","doi-asserted-by":"crossref","unstructured":"Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol 2012; 4(5): a008052.","DOI":"10.1101\/cshperspect.a008052"},{"issue":"6","key":"10.1016\/j.drudis.2021.07.012_b0335","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"49","key":"10.1016\/j.drudis.2021.07.012_b0340","doi-asserted-by":"crossref","first-page":"38437","DOI":"10.1074\/jbc.M007635200","article-title":"Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles","volume":"275","author":"Chi","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/BJ20060793","article-title":"Insulin-stimulated exocytosis of GLUT4 is enhanced by IRAP and its partner tankyrase","volume":"402","author":"Yeh","year":"2007","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.drudis.2021.07.012_b0350","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3892\/ijo.2016.3360","article-title":"Tankyrase 1 inhibitor XAV939 chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway","volume":"48","author":"Wu","year":"2016","journal-title":"Int. J Onco"},{"issue":"6","key":"10.1016\/j.drudis.2021.07.012_b0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ihj.2020.11.006","article-title":"Telomere length in young patients with acute myocardial infarction without conventional risk factors: a pilot study from a South Asian population","volume":"72","author":"Gupta","year":"2020","journal-title":"Indian Heart J"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2004.11.021","article-title":"Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics","volume":"7","author":"Seimiya","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2021.07.012_b0365","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2019.10813","article-title":"Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3-dimensional culture of colorectal cancer cells","author":"Kim","year":"2019","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.drudis.2021.07.012_b0370","first-page":"6585","article-title":"Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis","volume":"14","author":"Guo","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.drudis.2021.07.012_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.11.004","article-title":"IWR-1, a tankyrase inhibitor, attenuates Wnt\/\u03b2-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft","volume":"414","author":"Martins-Neves","year":"2018","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.drudis.2021.07.012_b0380","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1158\/0008-5472.CAN-12-4562","article-title":"A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth","volume":"73","author":"Lau","year":"2013","journal-title":"Cancer Res"},{"issue":"24","key":"10.1016\/j.drudis.2021.07.012_b0385","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1016\/j.bmcl.2015.10.079","article-title":"Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering","volume":"25","author":"Johannes","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.drudis.2021.07.012_b0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1574887110666150729125809","article-title":"Clinical trials of poly(ADP-Ribose) polymerase inhibitors for cancer therapy: a review","volume":"10","author":"Buege","year":"2015","journal-title":"Rev Recent Clin Trials"},{"issue":"17","key":"10.1016\/j.drudis.2021.07.012_b0395","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2174\/1568026614666140929115831","article-title":"Tankyrase inhibitors as therapeutic targets for cancer","volume":"14","author":"Kamal","year":"2014","journal-title":"Curr Top Med Chem"},{"issue":"22","key":"10.1016\/j.drudis.2021.07.012_b0400","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.1074\/jbc.RA117.001058","article-title":"Tankyrase modulates insulin sensitivity in skeletal muscle cells by regulating the stability of GLUT4 vesicle proteins","volume":"293","author":"Su","year":"2018","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0405","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1871520618666181109164645","article-title":"Poly (ADP-Ribose) polymerases (PARPs) and PARP inhibitor-targeted therapeutics","volume":"19","author":"Li","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"issue":"11","key":"10.1016\/j.drudis.2021.07.012_b0410","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1101\/gad.1077103","article-title":"TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres","volume":"17","author":"Chang","year":"2003","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0415","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1038\/s41467-019-12664-x","article-title":"Mice with hyper-long telomeres show less metabolic aging and longer lifespans","volume":"10","author":"Mu\u00f1oz-Lorente","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0420","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/cells8020186","article-title":"Targeting telomeres and telomerase: studies in aging and disease utilizing CRISPR\/Cas9 technology","volume":"8","author":"Brane","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.drudis.2021.07.012_b0425","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/cbin.11086","article-title":"RXXPEG motif of MERIT40 is required to maintain spindle structure and function through its interaction with Tankyrase1","volume":"43","author":"Zheng","year":"2019","journal-title":"Cell Biol Int"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0430","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41467-017-00054-0","article-title":"Interaction of tankyrase and peroxiredoxin II is indispensable for the survival of colorectal cancer cells","volume":"8","author":"Kang","year":"2017","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.drudis.2021.07.012_b0435","first-page":"10500","article-title":"Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.drudis.2021.07.012_b0440","article-title":"A genome-wide association study of copy-number variation identifies putative loci associated with osteoarthritis in Koreans","volume":"1676","author":"Moon","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"10.1016\/j.drudis.2021.07.012_b0445","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2012-202275","article-title":"Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling","volume":"72","author":"Distler","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.drudis.2021.07.012_b0450","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2009.03090.x","article-title":"Identification of a novel murine pancreatic tumour antigen, which elicits antibody responses in patients with pancreatic carcinoma","volume":"128","author":"Zhao","year":"2009","journal-title":"Immunology"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621003184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621003184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:51:53Z","timestamp":1761223913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644621003184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1359644621003184"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2021.07.012","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2021.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}